A phase II clinical trial is currently evaluating the efficacy and tolerability of front-line AMG-479, a fully-human monoclonal antibody against the IGF-1R, in combination with carboplatin and paclitaxel in advanced stage, optimally-debulked epithelial ovarian, primary peritoneal, and fallopian tube cancer (TRIO-014)
A certificate posted on a sellers website does not replace a valid prescription, pharmacy licensure, medical assessment, reliable sourcing, or accountability for the finished product
[DOI] [PubMed] [Google Scholar] 73.Zheng W, Wang B, Si M, et al
While oral supplementation is the most convenient, its also less effective due to glutathiones poor absorption in the digestive tract
Biochim et Biophys Acta
Cancer 4 , 793805 (2004)